We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+16.47%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$10.6B
AUM Growth
+$842M
Cap. Flow
-$440M
Cap. Flow %
-4.14%
Top 10 Hldgs %
16.26%
Holding
2,304
New
726
Increased
425
Reduced
494
Closed
615

Top Buys

Rank Stock Value
1
MCD icon
McDonald's
MCD
+$240M
2
TMO icon
Thermo Fisher Scientific
TMO
+$151M
3
BSX icon
Boston Scientific
BSX
+$121M
4
AMZN icon
Amazon
AMZN
+$104M
5
TRU icon
TransUnion
TRU
+$81M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 22.87%
2 Healthcare 20.58%
3 Financials 10.9%
4 Technology 10.13%
5 Industrials 8.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DNLI icon
1226
Denali Therapeutics
DNLI
$3.76B
$359K ﹤0.01%
+15,473
New +$324K
MRTX
1227
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$356K ﹤0.01%
4,853
+4,653
+2,327% +$317K
ALLK
1228
DELISTED
Allakos
ALLK
$355K ﹤0.01%
+8,769
New +$354K
TPVG icon
1229
TriplePoint Venture Growth BDC
TPVG
$184M
$354K ﹤0.01%
25,723
-49,137
-66% -$626K
TRUE
1230
DELISTED
TrueCar
TRUE
$352K ﹤0.01%
+53,058
New +$443K
B
1231
DELISTED
Barnes Group Inc.
B
$347K ﹤0.01%
+6,750
New +$384K
OMAD.WS
1232
DELISTED
One Madison Corporation
OMAD.WS
$345K ﹤0.01%
+300,000
New +$268K
GNK icon
1233
Genco Shipping & Trading
GNK
$1.11B
$344K ﹤0.01%
46,073
-164,885
-78% -$1.35M
CIR
1234
DELISTED
CIRCOR International, Inc
CIR
$344K ﹤0.01%
+10,560
New +$309K
PZN
1235
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$343K ﹤0.01%
+42,447
New +$379K
VRTV
1236
DELISTED
VERITIV CORPORATION
VRTV
$341K ﹤0.01%
+12,947
New +$396K
USX
1237
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$338K ﹤0.01%
51,142
-160,529
-76% -$1.25M
MTB icon
1238
M&T Bank
MTB
$36.2B
$337K ﹤0.01%
2,147
+1,676
+356% +$275K
CDLX icon
1239
Cardlytics
CDLX
$21.7M
$336K ﹤0.01%
+2,033
New +$331K
NTWK icon
1240
NetSol Technologies
NTWK
$52.7M
$328K ﹤0.01%
50,340
+43,988
+693% +$313K
CORR
1241
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
$326K ﹤0.01%
+8,866
New +$319K
KALA icon
1242
KALA BIO
KALA
$12.7M
$325K ﹤0.01%
+16
New +$284K
UROV
1243
DELISTED
Urovant Sciences Ltd.
UROV
$325K ﹤0.01%
+32,329
New +$331K
AVID
1244
DELISTED
Avid Technology Inc
AVID
$324K ﹤0.01%
+43,474
New +$226K
CCS icon
1245
Century Communities
CCS
$2.04B
$322K ﹤0.01%
+13,435
New +$305K
CCK icon
1246
Crown Holdings
CCK
$12.9B
$321K ﹤0.01%
+5,876
New +$303K
HOLX
1247
DELISTED
Hologic
HOLX
$321K ﹤0.01%
6,623
-158,982
-96% -$7.17M
VSTM icon
1248
Verastem
VSTM
$554M
$319K ﹤0.01%
+8,987
New +$355K
AXDX
1249
DELISTED
Accelerate Diagnostics
AXDX
$318K ﹤0.01%
+1,514
New +$284K
TBBK icon
1250
The Bancorp
TBBK
$2.81B
$318K ﹤0.01%
39,371
-206,916
-84% -$1.79M

Similar funds

Marshall Wace's Q1 2019 Portfolio in Review

As of Q1 2019, Marshall Wace held 2,304 positions worth $10.6B, up 8.6% from $9.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace withdrew a net $440M in Q1 2019, closing 615 positions and reducing 494 holdings. Its most notable exit was Shire pic, an estimated $166M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 23% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Marshall Wace opened a new position in TransUnion worth $87.4M.

  • Marshall Wace's largest Q1 2019 buy was TransUnion: 1,307,679 shares worth $87.4M.
  • Marshall Wace added most to McDonald's in Q1 2019, an estimated $240M increase.
  • Marshall Wace's biggest Q1 2019 reduction was Alphabet (Google) Class A, cutting an estimated $132M.
  • Marshall Wace fully exited Shire pic in Q1 2019, selling an estimated $166M.
  • Marshall Wace's ten largest holdings make up 16% of its $10.6B portfolio in Q1 2019.
  • Marshall Wace opened 726 new positions and closed 615 in Q1 2019.
  • Marshall Wace's portfolio value rose 8.6% quarter-over-quarter to $10.6B.

Based on Marshall Wace's 13F filing for Q1 2019, filed 14 May 2019.